BioNTech SE SEC filings BNTX
BioNTech SE has 589 filings in SEC EDGAR's recent list, going back to Jun 19, 2019. Its latest annual report, Form 20-F, was filed on Mar 10, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Nov 14, 2025 | — |
| F-4/A | Filing | Oct 21, 2025 | — |
| F-4/A | Filing | Sep 8, 2025 | — |
| F-4 | Filing | Aug 11, 2025 | — |
| S-8 | Employee stock plan registration | Feb 15, 2024 | — |
| S-8 | Employee stock plan registration | Feb 13, 2023 | — |
| S-8 POS | Filing | Feb 13, 2023 | — |
| S-8 | Employee stock plan registration | Feb 18, 2021 | — |
| F-3ASR | Filing | Nov 10, 2020 | — |
| 424B3 | Prospectus | Aug 27, 2020 | — |
| 424B3 | Prospectus | Aug 21, 2020 | — |
| 424B3 | Prospectus | Aug 12, 2020 | — |
| 424B3 | Prospectus | Aug 11, 2020 | — |
| 424B3 | Prospectus | Aug 5, 2020 | — |
| 424B3 | Prospectus | Jul 31, 2020 | — |
| 424B3 | Prospectus | Jul 28, 2020 | — |
| 424B5 | Prospectus supplement | Jul 24, 2020 | — |
| F-1/A | Filing | Jul 23, 2020 | — |
| F-1MEF | Filing | Jul 22, 2020 | — |
| F-1/A | Filing | Jul 22, 2020 | — |
| FWP | Free writing prospectus | Jul 22, 2020 | — |
| FWP | Free writing prospectus | Jul 22, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jul 21, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Jul 21, 2020 | — |
| 424B3 | Prospectus | Apr 2, 2020 | — |
| F-4 | Filing | Apr 1, 2020 | — |
| F-1 | Registration statement (foreign issuer) | Feb 3, 2020 | — |
| 424B4 | Prospectus | Oct 11, 2019 | — |
| FWP | Free writing prospectus | Oct 10, 2019 | — |
| F-1/A | Filing | Oct 9, 2019 | — |
| F-1/A | Filing | Oct 4, 2019 | — |
| F-1/A | Filing | Sep 24, 2019 | — |
| F-1 | Registration statement (foreign issuer) | Sep 9, 2019 | — |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- BNTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Germany
- Headquarters
- Mainz, Germany
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1776985
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.